BINYAMINA, Israel, June 16, 2021 /PRNewswire/ — OncoHost, global leader in host response profiling for improved personalized cancer therapy, today announced a collaboration with the United Kingdom National Health Service (NHS), launching eight clinical trial sites in the UK. These trials will provide proteomic analysis for patients diagnosed with advanced stages of melanoma or non-small cell lung cancer (NSCLC) receiving immunotherapy, to help predict their response to treatment.
Read more here.
![[The Bouqs in AMNY] Here are a few creative ways to celebrate birthdays and special occasions in New York City](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
![[Hailo in TechCrunch] Hailo lands $120 million to keep battling Nvidia as most AI chip startups struggle](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-link.svg)
